Literature DB >> 15191849

[Reoperation for persistent or recurrent primary hyperparathyroidism. Seventy-seven cases among 1888 operated patients].

L Arnalsteen1, J L Quievreux, D Huglo, F Pattou, B Carnaille, C Proye.   

Abstract

AIMS: To analyse the results of re-operations for persistent (p) or recurrent (r) primary hyperparathyroidism (PHPT). PATIENTS AND METHODS: From 1965 throughout 2001, 1888 patients were operated on for PHPT. The cure rate after initial surgery was 97.6%. Seventy-seven (4.1%) were reoperated for p PHPT (n = 54) or r PHPT (n = 23). Thirty-two out of 77 (41%) had been primarily operated elsewhere. In 15 cases (20%) PHPT was genetically determined. The re-operation was undertaken on average 40.7 months after initial surgery (1 day-190 months).
RESULTS: Two out of 77 were cases of familial hypocalciuric hypercalcaemia. Among the 75 patients reoperated for true PHPT, 23 (31%) had uniglandular disease (UGD) and 52 (69%) had multiglandular disease (MGD). There were two cases of recurrent parathyroid carcinoma. Overall 97 pathological glands were resected, 37% being orthotopic and 63% heterotopic. The re-operation was performed by a cervical approach in 80%, by a mediastinal approach in 15%, whereas 5% involved excision of antebrachial implants. In 96% of cases the parathyroid glands were in the cervical position. Among the preoperative localisations studies the sensitivity of scintigraphy utilising 2-methoxyisobutyl-isonitril (MIBI) was 61%. Utilising both MIBI and cervical ultrasound the sensitivity was 64%. Sixty-eight out of 75 (91%) were cured of their hypercalcaemia, but at the cost of permanent hypoparathyroidism in 9% of cases. No sporadic adenoma appears to have been missed. The seven failures after re-operation (9%) involved five cases of MGD, of which four were sporadic, two cases of carcinoma and one case of parathyreomatosis. 39 patients (51%) had more than four parathyroid glands and in 22/39 cases at least one supernumerary gland was pathological.
CONCLUSION: The re-operations for PHPT were essentially due to MGD that was either sporadic or genetically determined. Often the offending supernumerary gland was not detected by imaging studies. Avoiding failures entails an initial bilateral cervicotomy with thymic exploration after MIBI scintigraphy to exclude a mediastinal focus.

Entities:  

Mesh:

Year:  2004        PMID: 15191849     DOI: 10.1016/j.anchir.2004.03.007

Source DB:  PubMed          Journal:  Ann Chir        ISSN: 0003-3944


  6 in total

Review 1.  [Localization of parathyroid adenomas with C11-methionine PET-CT].

Authors:  T Weber; M Luster
Journal:  Chirurg       Date:  2014-07       Impact factor: 0.955

2.  Virtual neck exploration in patients with hyperparathyroidism and former cervical operations.

Authors:  Gerd Wimmer; Reto Bale; Peter Kovacs; Michael Gabriel; Daniel Putzer; Tonja Sauper; Michael Sieb; Christoph Profanter; Raimund Margreiter; Rupert Prommegger
Journal:  Langenbecks Arch Surg       Date:  2008-06-25       Impact factor: 3.445

Review 3.  Surgical strategy for sporadic primary hyperparathyroidism an evidence-based approach to surgical strategy, patient selection, surgical access, and reoperations.

Authors:  Radu Mihai; Marcin Barczynski; Maurizio Iacobone; Antonio Sitges-Serra
Journal:  Langenbecks Arch Surg       Date:  2009-06-25       Impact factor: 3.445

4.  Monocentric experience of primary hyperparathyroidism surgery in Algeria.

Authors:  Souad Nouikes Zitouni
Journal:  Surg Open Sci       Date:  2021-02-10

Review 5.  Surgical approach in patients with hyperparathyroidism in multiple endocrine neoplasia type 1: total versus partial parathyroidectomy.

Authors:  Francesco Tonelli; Francesco Giudici; Tiziana Cavalli; Maria Luisa Brandi
Journal:  Clinics (Sao Paulo)       Date:  2012       Impact factor: 2.365

6.  Evaluation of diagnostic efficacy for localization of parathyroid adenoma in patients with primary hyperparathyroidism undergoing repeat surgery.

Authors:  Anne Hendricks; Christina Lenschow; Matthias Kroiss; Andreas Buck; Ralph Kickuth; Christoph-Thomas Germer; Nicolas Schlegel
Journal:  Langenbecks Arch Surg       Date:  2021-05-16       Impact factor: 3.445

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.